Abstract
Research Overview
This analysis is available through our Drug Discovery Technologies Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.
Technologies
The following technologies are covered in this research:
- Custom, pre-designed, or validated siRNA; siRNA sets; genome-wide libraries;
- shRNA; expression cassettes; miRNA
- Lipid-based transfection reagents; RNAi-specific transfection reagents;
- electroporation devices and buffers; viral vectors; nano-particle technologies
- Quantitative real time PCR assays; Northern blot kits; gene expression arrays;
- western blot kits; 2D gel electrophoresis consumables; proteomics arrays;
- phenotypic assays
Market Overview
The U.S. RNAi markets are rapidly evolving as a growing number of scientists transition their research focus from low-throughput to medium- and high-throughput in one dimension, and from in vitro to in vivo in a second dimension. Numerous opportunities exist for vendors of RNAi content and tools, especially as technologies advance to provide greater selectivity and specificity of knockdown. RNAi technologies are proving to be indispensable tools for functional genomics research and for identifying and validating potential drug targets. RNAi has become a vital tool for examining both gene and protein expression analyses, especially with regards to understanding the pre- and post-transcriptional function of genes in relation to disease. Using RNAi, researchers are able to simply turn genes on and off and observe what happens, thereby gaining insights into how genes participate in cellular processes. RNAi is by far the most widely used gene-silencing technique employed in research.
Table of Contents
- 1. Executive Summary
- 1. Market Overview
- 1. Introduction
- 1. Market Overview
- 2. Total RNAi Market
- 1. Market Overview
- 1. Introduction
- 2. Scope and Segmentation
- 3. Research Methodology
- 4. Market Engineering Measurements
- 2. Market Forecast and Competitive Analysis
- 1. Revenue Forecasts
- 2. Competitive Structure
- 3. Market Share Analysis
- 4. Partnerships and Mergers & Acquisitions
- 3. Market Challenges and Strategic Recommendations
- 1. Industry Challenges
- 2. Strategic Recommendations
- 1. Market Overview
- 3. RNAi Content Market
- 1. Market Overview
- 1. Introduction
- 2. Market Engineering Measurements
- 2. Market Drivers and Restraints
- 1. Market Drivers
- 2. Market Restraints
- 3. Technology and Market Trends
- 1. Technology Trends
- 2. Market Trends
- 4. Market Forecasts and Competitive Analysis
- 1. Revenue Forecasts
- 2. Competitive Structure
- 3. Market Share Analysis
- 1. Market Overview
- 4. RNAi Delivery Tools Market
- 1. Market Overview
- 1. Introduction
- 2. Market Engineering Measurements
- 2. Market Drivers and Restraints
- 1. Market Drivers
- 2. Market Restraints
- 3. Technology and Market Trends
- 1. Technology Trends
- 2. Market Trends
- 4. Market Forecasts and Competitive Analysis
- 1. Revenue Forecasts
- 2. Competitive Structure
- 3. Market Share Analysis
- 1. Market Overview
- 5. RNAi Screening and Analysis Tools Market
- 1. Market Overview
- 1. Introduction
- 2. Market Engineering Measurements
- 2. Market Drivers and Restraints
- 1. Market Drivers
- 2. Market Restraints
- 3. Technology and Market Trends
- 1. Technology Trends
- 2. Market Trends
- 4. Market Forecasts and Competitive Analysis
- 1. Revenue Forecasts
- 2. Competitive Structure
- 3. Market Share Analysis
- 1. Market Overview
- 6. Decision Support Database
- 1. Decision Support Database
- 1. Pharmaceutical R&D Expenditure
- 2. Government R&D Investment in Biotechnology
- 3. Private Investment in Biotechnology
- 4. Number of Biotechnology Companies
- 5. Students Enrolled for Graduation and Postgraduation Courses
- 1. Decision Support Database
- List of Figures
- Total RNAi Markets: Revenue Forecasts (U.S.), 2002-2012
- Total RNAi Markets: Revenues Forecasts by Segment (U.S.), 2002-2012
- Total RNAi Markets: Percent of Revenues by Segment (U.S.), 2002-2012
- Total RNAi Markets: Competitive Structure (U.S.), 2005
- Total RNAi Markets: Company Market Share by Revenues (U.S.), 2005
- Total RNAi Markets: Impact of Top Industry Challenges (U.S.), 2006-2012
- Total RNAi Markets: Challenges and Corresponding Strategic Recommendations (U.S.), 2006-2012
- RNAi Content Market: Market Drivers Ranked in Order of Impact (U.S.), 2006-2012
- RNAi Content Market: Market Restraints Ranked in Order of Impact (U.S.), 2006-2012
- RNAi Content Market: National Institutes of Health RNAi Related Funding (U.S.), 2006
- RNAi Content Market: Revenue Forecasts (U.S.), 2002-2012
- RNAi Content Market: Revenues Forecasts by Sub-Segment (U.S.), 2002-2012
- RNAi Content Market: Percent of Revenues by Sub-Segment (U.S.), 2002-2012
- RNAi Content Market: Competitive Structure (U.S.), 2005
- RNAi Content Market: Company Market Share by Revenues (U.S.), 2005
- RNAi Delivery Tools Market: Market Drivers Ranked in Order of Impact (U.S.), 2006-2012
- RNAi Delivery Tools Market: Market Restraints Ranked in Order of Impact (U.S.), 2006-2012
- RNAi Delivery Tools Market: Revenue Forecasts (U.S.), 2002-2012
- RNAi Delivery Tools Market: Competitive Structure (U.S.), 2005
- RNAi Delivery Tools Market: Company Market Share by Revenues (U.S.), 2005
- RNAi Screening and Analysis Tools Market: Market Drivers Ranked in Order of Impact U.S.), 2006-2012
- RNAi Screening and Analysis Tools Market: Market Restraints Ranked in Order of Impact (U.S.), 2006-2012
- RNAi Screening and Analysis Tools Market: Revenue Forecasts (U.S.), 2002-2012
- RNAi Screening and Analysis Tools Market: Competitive Structure (U.S.), 2005
- RNAi Screening and Analysis Tools Market: Company Market Share by Revenues (U.S.), 2005
